Skip to main content
. 2017 May 23;12(5):e0176182. doi: 10.1371/journal.pone.0176182

Fig 4. Effects of chronic treatment with MK-2305 on lipids and HBA1c in the GK rat.

Fig 4

Effects of vehicle, Rosiglitazone, and MK-2305 on rat (A) NEFA, (B) liver TG, and (C) HbA1c following 20 days of treatment. Data were analyzed via ANOVA followed by Dunnets test comparing Rosiglitazone or MK-2305 treatments with vehicle. *p<0.05, ***p<0.001.